The ANCA test: its clinical relevance.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. The clinical utility of ANCA positivity.Annals of the rheumatic diseases · 1996
   Review
2. An audit of ANCA in routine clinical practice.Postgraduate medical journal · 1995
   Article
3. Angiotropic lymphoma in the differential diagnosis of systemic vasculitis.Journal of neurology, neurosurgery, and psychiatry · 1995
   Article
4. Wegener's granulomatosis and the heart.British heart journal · 1994
   Review
5. ANCA associated with scleritis and sclerosing keratitis.Clinical rheumatology · 1993
   Article
6. The spectrum of disease associated with a positive ANCA.Clinical rheumatology · 1993
   Article
7. Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders.Annals of the rheumatic diseases · 1993
   Article
8. Systemic vasculitis.BMJ (Clinical research ed.) · 1992
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as